Literature DB >> 25592036

Building immunity to cancer with radiation therapy.

Suresh J Haikerwal1, Jim Hagekyriakou2, Michael MacManus3, Olga A Martin4, Nicole M Haynes5.   

Abstract

Over the last decade there has been a dramatic shift in the focus of cancer research toward understanding how the body's immune defenses can be harnessed to promote the effectiveness of cytotoxic anti-cancer therapies. The ability of ionizing radiation to elicit anti-cancer immune responses capable of controlling tumor growth has led to the emergence of promising combination-based radio-immunotherapeutic strategies for the treatment of cancer. Herein we review the immunoadjuvant properties of localized radiation therapy and discuss how technological advances in radio-oncology and developments in the field of tumor-immunotherapy have started to revolutionize the therapeutic application of radiotherapy.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Anti-tumor immunity; Cancer; Immunogenic cell death; Immunotherapy; Ionizing radiation; Radiotherapy

Mesh:

Year:  2015        PMID: 25592036     DOI: 10.1016/j.canlet.2015.01.009

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  25 in total

1.  Perilesional edema in brain metastasis from non-small cell lung cancer (NSCLC) as predictor of response to radiosurgery (SRS).

Authors:  Paolo Tini; Valerio Nardone; Pierpaolo Pastina; Giuseppe Battaglia; Claudia Vinciguerra; Tommaso Carfagno; Giovanni Rubino; Salvatore Francesco Carbone; Lucio Sebaste; Alfonso Cerase; Antonio Federico; Luigi Pirtoli
Journal:  Neurol Sci       Date:  2017-03-04       Impact factor: 3.307

Review 2.  Functional response difference between diabetic/normal cancerous patients to inflammatory cytokines and oxidative stresses after radiotherapy.

Authors:  Parinaz Mehnati; Behzad Baradaran; Fatemeh Vahidian; Sousan Nadiriazam
Journal:  Rep Pract Oncol Radiother       Date:  2020-06-30

3.  Abscopal effect of radiation on bone metastases of breast cancer: A case report.

Authors:  Henry Wc Leung; Shyh-Yau Wang; Huang Jin-Jhih; Agnes Lf Chan
Journal:  Cancer Biol Ther       Date:  2017-12-27       Impact factor: 4.742

4.  Identification of a highly immunogenic mouse breast cancer sub cell line, 4T1-S.

Authors:  Hirotake Abe; Haruka Wada; Muhammad Baghdadi; Sayaka Nakanishi; Yuu Usui; Takahiro Tsuchikawa; Toshiaki Shichinohe; Satoshi Hirano; Ken-Ichiro Seino
Journal:  Hum Cell       Date:  2016-02-08       Impact factor: 4.174

Review 5.  Does the mobilization of circulating tumour cells during cancer therapy cause metastasis?

Authors:  Olga A Martin; Robin L Anderson; Kailash Narayan; Michael P MacManus
Journal:  Nat Rev Clin Oncol       Date:  2016-08-23       Impact factor: 66.675

Review 6.  Immunotherapy in colorectal cancer: for the select few or all?

Authors:  Sukeshi Patel Arora; Devalingam Mahalingam
Journal:  J Gastrointest Oncol       Date:  2018-02

7.  Combining ablative radiotherapy and anti CD47 monoclonal antibody improves infiltration of immune cells in tumor microenvironments.

Authors:  Elham Rostami; Mohsen Bakhshandeh; Haniyeh Ghaffari-Nazari; Maedeh Alinezhad; Masoumeh Alimohammadi; Reza Alimohammadi; Ghanbar Mahmoodi Chalbatani; Ehsan Hejazi; Thomas J Webster; Jalil Tavakkol-Afshari; Seyed Amir Jalali
Journal:  PLoS One       Date:  2022-08-26       Impact factor: 3.752

Review 8.  Advantages and Limitations in the Use of Combination Therapies with Charged Particle Radiation Therapy.

Authors:  Koji Tsuboi
Journal:  Int J Part Ther       Date:  2018-09-21

Review 9.  Multidiscipline Immunotherapy-Based Rational Combinations for Robust and Durable Efficacy in Brain Metastases from Renal Cell Carcinoma.

Authors:  Hye-Won Lee
Journal:  Int J Mol Sci       Date:  2021-06-11       Impact factor: 5.923

Review 10.  Modern Radiotherapy Concepts and the Impact of Radiation on Immune Activation.

Authors:  Lisa Deloch; Anja Derer; Josefin Hartmann; Benjamin Frey; Rainer Fietkau; Udo S Gaipl
Journal:  Front Oncol       Date:  2016-06-20       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.